BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19063683)

  • 1. Mathematical modeling of spatio-temporal dynamics of a single bone multicellular unit.
    Ryser MD; Nigam N; Komarova SV
    J Bone Miner Res; 2009 May; 24(5):860-70. PubMed ID: 19063683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.
    Luo XH; Guo LJ; Xie H; Yuan LQ; Wu XP; Zhou HD; Liao EY
    J Bone Miner Res; 2006 Oct; 21(10):1648-56. PubMed ID: 16995820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
    Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
    Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of bone cell function by RANKL and OPG in different in vitro models.
    Lin JM; Callon KE; Lin CQ; Bava U; Zheng MH; Reid IR; Cornish J
    Eur J Clin Invest; 2007 May; 37(5):407-15. PubMed ID: 17461987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical investigation of the role of the RANK-RANKL-OPG system in bone remodeling.
    Pivonka P; Zimak J; Smith DW; Gardiner BS; Dunstan CR; Sims NA; Martin TJ; Mundy GR
    J Theor Biol; 2010 Jan; 262(2):306-16. PubMed ID: 19782692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice.
    Cao J; Venton L; Sakata T; Halloran BP
    J Bone Miner Res; 2003 Feb; 18(2):270-7. PubMed ID: 12568404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RANK/RANKL/OPG triad in cancer-induced bone diseases.
    Dougall WC; Chaisson M
    Cancer Metastasis Rev; 2006 Dec; 25(4):541-9. PubMed ID: 17180711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
    Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
    Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical stimulation effects on functional end effectors in osteoblastic MG-63 cells.
    Saunders MM; Taylor AF; Du C; Zhou Z; Pellegrini VD; Donahue HJ
    J Biomech; 2006; 39(8):1419-27. PubMed ID: 15953606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells.
    Poulsen RC; Wolber FM; Moughan PJ; Kruger MC
    Prostaglandins Other Lipid Mediat; 2008 Feb; 85(1-2):42-8. PubMed ID: 18077200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity.
    Lossdörfer S; Schwartz Z; Wang L; Lohmann CH; Turner JD; Wieland M; Cochran DL; Boyan BD
    J Biomed Mater Res A; 2004 Sep; 70(3):361-9. PubMed ID: 15293309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.
    Yonou H; Horiguchi Y; Ohno Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
    Prostate; 2007 Jun; 67(8):840-8. PubMed ID: 17394194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case for strain-induced fluid flow as a regulator of BMU-coupling and osteonal alignment.
    Smit TH; Burger EH; Huyghe JM
    J Bone Miner Res; 2002 Nov; 17(11):2021-9. PubMed ID: 12412810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio.
    Rucci N; Rufo A; Alamanou M; Teti A
    J Cell Biochem; 2007 Feb; 100(2):464-73. PubMed ID: 16927271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of arachidonic acid, docosahexaenoic acid, prostaglandin E(2) and parathyroid hormone on osteoprotegerin and RANKL secretion by MC3T3-E1 osteoblast-like cells.
    Coetzee M; Haag M; Kruger MC
    J Nutr Biochem; 2007 Jan; 18(1):54-63. PubMed ID: 16650751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A theoretical model for simulating effect of parathyroid hormone on bone metabolism at cellular level.
    Wang Y; Qin QH; Kalyanasundaram S
    Mol Cell Biomech; 2009 Jun; 6(2):101-12. PubMed ID: 19496258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone.
    Parfitt AM
    J Cell Biochem; 1994 Jul; 55(3):273-86. PubMed ID: 7962158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New paradigms in the regulation of bone metabolism].
    Rosa-Rañal M; de la Cruz DA; Lorena-Rubio Y; Larrea F
    Rev Invest Clin; 2001; 53(4):362-9. PubMed ID: 11599485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct effects of osteoprotegerin on human bone cell metabolism.
    Grundt A; Grafe IA; Liegibel U; Sommer U; Nawroth P; Kasperk C
    Biochem Biophys Res Commun; 2009 Nov; 389(3):550-5. PubMed ID: 19748486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.